{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:53:30Z","timestamp":1778900010381,"version":"3.51.4"},"reference-count":59,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Adult T-cell leukemia\/lymphoma (ATL) is a human T-cell leukemia virus type 1 (HTLV-1)\u2013associated T-cell malignancy with generally poor prognosis. Although only \u223c5% of HTLV-1 carriers progress to ATL, early diagnosis is challenging because of the lack of ATL biomarkers. In this study, we analyzed blood plasma profiles of asymptomatic HTLV-1 carriers (ACs); untreated ATL patients, including acute, lymphoma, smoldering, and chronic types; and ATL patients in remission. Through SOMAscan, expression levels of 1305 plasma proteins were analyzed in 85 samples (AC, n = 40; ATL, n = 40; remission, n = 5). Using gene set enrichment analysis and gene ontology, overrepresented pathways in ATL vs AC included angiogenesis, inflammation by cytokines and chemokines, interleukin-6 (IL-6)\/JAK\/STAT3, and notch signaling. In selecting candidate biomarkers, we focused on soluble tumor necrosis factor receptor 2 (sTNFR2) because of its active role in enriched pathways, extreme significance (Welch\u2019s t test P &amp;lt; .00001), high discrimination capacity (area under the curve &amp;gt;0.90), and novelty in ATL research. Quantification of sTNFR2 in 102 plasma samples (AC, n = 30; ATL, n = 68; remission, n = 4) using enzyme-linked immunosorbent assay showed remarkable elevations in acute ATL, at least 10 times those of AC samples, and return of sTNFR2 to AC state levels after achieving remission. Flow cytometry and immunostaining validated the expression of TNFR2 in ATL cells. No correlation between sIL-2 and sTNFR2 levels in acute ATL was found, suggesting the possibility of sTNFR2 as an independent biomarker. Our findings represent the first extensive blood-based proteomic analysis of ATL, suggesting the potential clinical utility of sTNFR2 in diagnosing acute ATL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001429","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T15:40:10Z","timestamp":1584718810000},"page":"1062-1071","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-0775","authenticated-orcid":false,"given":"Carmina Louise Hugo","family":"Guerrero","sequence":"first","affiliation":[{"name":"Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Yamashita","sequence":"first","affiliation":[{"name":"AI Drug Development Division, NEC Corporation, Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Miyara","sequence":"first","affiliation":[{"name":"Department of Health and Nutrition, Faculty of Health and Nutrition, Okinawa University, Naha, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Imaizumi","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Genetics, Graduate School of Health Sciences, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Kato","sequence":"first","affiliation":[{"name":"Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugo","family":"Sakihama","sequence":"first","affiliation":[{"name":"Department of Pathology and Cell Biology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Hematology, Nakagami Hospital, Okinawa City, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miyagi","sequence":"first","affiliation":[{"name":"Department of Hematology, Heart Life Hospital, Nakagusuku, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Karimata","sequence":"first","affiliation":[{"name":"Department of Hematology, Heart Life Hospital, Nakagusuku, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnosuke","family":"Uchihara","sequence":"first","affiliation":[{"name":"Department of Hematology, Naha City Hospital, Naha, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuiku","family":"Ohshiro","sequence":"first","affiliation":[{"name":"Department of Hematology, Okinawa Prefectural Nambu Medical Center and Children\u2019s Medical Center, Haebaru, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpei","family":"Todoroki","sequence":"first","affiliation":[{"name":"Department of Hematology, Chubu Tokushukai Hospital, Nakagami, Japan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Nakachi","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Morishima","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-858X","authenticated-orcid":false,"given":"Kennosuke","family":"Karube","sequence":"first","affiliation":[{"name":"Department of Pathology and Cell Biology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetsu","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Immunology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Masuzaki","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-2875","authenticated-orcid":false,"given":"Takuya","family":"Fukushima","sequence":"first","affiliation":[{"name":"Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"issue":"3","key":"2020042008481937200_B1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"issue":"12","key":"2020042008481937200_B2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2020042008481937200_B3","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2020042008481937200_B4","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2020042008481937200_B5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"1","key":"2020042008481937200_B6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1346-8138.12374","article-title":"Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma","volume":"41","author":"Tsukasaki","year":"2014","journal-title":"J Dermatol"},{"issue":"8","key":"2020042008481937200_B7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J Clin Oncol"},{"issue":"34","key":"2020042008481937200_B8","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"issue":"27","key":"2020042008481937200_B9","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"22","key":"2020042008481937200_B10","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"2020042008481937200_B11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"2020042008481937200_B12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front Microbiol"},{"key":"2020042008481937200_B13","first-page":"2534","article-title":"Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease","volume-title":"Proc Natl Acad Sci U S A","author":"Yoshida","year":"1984"},{"issue":"39","key":"2020042008481937200_B14","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"issue":"3","key":"2020042008481937200_B15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"2020042008481937200_B16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2020042008481937200_B17","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: a nationwide survey","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci"},{"issue":"32","key":"2020042008481937200_B18","doi-asserted-by":"crossref","first-page":"51981","DOI":"10.18632\/oncotarget.10223","article-title":"Adult T-cell leukemia\/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy","volume":"7","author":"Zell","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"2020042008481937200_B19","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1038\/s41598-018-23505-0","article-title":"Proteomic analysis of plasma extracellular vesicles reveals mitochondrial stress upon HTLV-1 infection","volume":"8","author":"Jeannin","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"2020042008481937200_B20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2257.2005.00698.x","article-title":"Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells","volume":"27","author":"Kamihira","year":"2005","journal-title":"Clin Lab Haematol"},{"issue":"2","key":"2020042008481937200_B21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"2020042008481937200_B22","author":"World Health Organization","year":"1979"},{"issue":"12","key":"2020042008481937200_B23","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"2020042008481937200_B24","author":"SomaLogic","year":"2015"},{"issue":"11","key":"2020042008481937200_B25","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-13-3169","article-title":"CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia\/lymphoma","volume":"20","author":"Kobayashi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2020042008481937200_B26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ijnp\/pyy013","article-title":"Plasma levels of soluble tumor necrosis factor receptor 2 (STNFR2) are associated with hippocampal volume and cognitive performance in patients with schizophrenia","volume":"21","author":"Kudo","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"2020042008481937200_B27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjp.0704549","article-title":"TNF ligands and receptors\u2014a matter of life and death","volume":"135","author":"MacEwan","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2020042008481937200_B28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0092-8674(93)90464-2","article-title":"A novel domain within the 55 kd TNF receptor signals cell death","volume":"74","author":"Tartaglia","year":"1993","journal-title":"Cell"},{"issue":"6","key":"2020042008481937200_B29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"2020042008481937200_B30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"2020042008481937200_B31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2020042008481937200_B32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12185-018-02580-z","article-title":"Association of high levels of plasma OX40 with acute adult T-cell leukemia","volume":"109","author":"Tanaka","year":"2019","journal-title":"Int J Hematol"},{"issue":"5","key":"2020042008481937200_B33","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1084\/jem.183.5.2185","article-title":"The human OX40\/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells","volume":"183","author":"Imura","year":"1996","journal-title":"J Exp Med"},{"key":"2020042008481937200_B34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1743-422X-10-338","article-title":"Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus","volume":"10","author":"Kasahara","year":"2013","journal-title":"Virol J"},{"issue":"3","key":"2020042008481937200_B35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2020042008481937200_B36","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood.V86.8.3109.3109","article-title":"Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax","volume":"86","author":"Tatewaki","year":"1995","journal-title":"Blood"},{"issue":"5","key":"2020042008481937200_B37","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1182\/blood.V82.5.1590.1590","article-title":"E-selectin and vascular cell adhesion molecule-1 mediate adult T-cell leukemia cell adhesion to endothelial cells","volume":"82","author":"Ishikawa","year":"1993","journal-title":"Blood"},{"issue":"5694","key":"2020042008481937200_B38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"3","key":"2020042008481937200_B39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/leu.2014.241","article-title":"Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model","volume":"29","author":"Yu","year":"2015","journal-title":"Leukemia"},{"key":"2020042008481937200_B40","doi-asserted-by":"crossref","unstructured":"Asano\n              N\n            , MiyoshiH, KatoT, et al Expression pattern of immunosurveillance-related antigen is a critical prognostic factor of adult T-cell leukemia\/lymphoma [abstract]. Blood. 2016;128(22). Abstract 4135.","DOI":"10.1182\/blood.V128.22.4135.4135"},{"key":"2020042008481937200_B41","doi-asserted-by":"crossref","unstructured":"Niino\n              D\n            , KomoharaY, KimuraY, et al M2 macrophage infiltration is closely associated with poor prognosis for adult T-cell leukemia\/lymphoma (ATLL). Blood. 2011;118(21). Abstract 3672.","DOI":"10.1182\/blood.V118.21.3672.3672"},{"key":"2020042008481937200_B42","first-page":"85","article-title":"A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells","volume":"1","author":"Ohyashiki","year":"2008","journal-title":"Adv Appl Bioinform Chem"},{"issue":"2","key":"2020042008481937200_B43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrd3930","article-title":"Clinical targeting of the TNF and TNFR superfamilies","volume":"12","author":"Croft","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"2020042008481937200_B44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.molmed.2017.09.007","article-title":"TNFR2: a novel target for cancer immunotherapy","volume":"23","author":"Vanamee","year":"2017","journal-title":"Trends Mol Med"},{"key":"2020042008481937200_B45","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3389\/fimmu.2018.01274","article-title":"Increased regulatory T cells in peripheral blood of acute myeloid leukemia patients rely on tumor necrosis factor (TNF)-\u03b1-TNF receptor-2 pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"2020042008481937200_B46","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/s41375-018-0292-9","article-title":"Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced S\u00e9zary syndrome","volume":"33","author":"Torrey","year":"2019","journal-title":"Leukemia"},{"issue":"13","key":"2020042008481937200_B47","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1158\/1078-0432.CCR-11-3299","article-title":"Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma","volume":"18","author":"Heemann","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2020042008481937200_B48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2013.00478","article-title":"TNF receptor 2 and disease: autoimmunity and regenerative medicine","volume":"4","author":"Faustman","year":"2013","journal-title":"Front Immunol"},{"issue":"5","key":"2020042008481937200_B49","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The TNF receptor superfamily in co-stimulating and co-inhibitory responses","volume":"44","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"issue":"11","key":"2020042008481937200_B50","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.bbamcr.2017.07.001","article-title":"The shedding protease ADAM17: physiology and pathophysiology","volume":"1864","author":"Zunke","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"6","key":"2020042008481937200_B51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2559.1995.tb00272.x","article-title":"CD30 (Ki-1) expression in adult T-cell leukaemia\/lymphoma is associated with distinctive immunohistological and clinical characteristics","volume":"26","author":"Takeshita","year":"1995","journal-title":"Histopathology"},{"issue":"11","key":"2020042008481937200_B52","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1349-7006.2005.00106.x","article-title":"Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia\/lymphoma","volume":"96","author":"Nishioka","year":"2005","journal-title":"Cancer Sci"},{"issue":"5","key":"2020042008481937200_B53","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood.V70.5.1407.1407","article-title":"Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia","volume":"70","author":"Maeda","year":"1987","journal-title":"Blood"},{"issue":"2","key":"2020042008481937200_B54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/mcbr.1999.0117","article-title":"Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells","volume":"1","author":"Halfter","year":"1999","journal-title":"Mol Cell Biol Res Commun"},{"key":"2020042008481937200_B55","doi-asserted-by":"crossref","first-page":"512103","DOI":"10.1155\/2013\/512103","article-title":"The enigmatic cytokine oncostatin m and roles in disease","volume":"2013","author":"Richards","year":"2013","journal-title":"ISRN Inflamm"},{"issue":"5","key":"2020042008481937200_B56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","article-title":"Oncostatin M and interleukin-31: cytokines, receptors, signal transduction and physiology","volume":"26","author":"Hermanns","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"2020042008481937200_B57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2141.1998.00538.x","article-title":"Circulating interleukin-6 levels are elevated in adult T-cell leukaemia\/lymphoma patients and correlate with adverse clinical features and survival","volume":"100","author":"Yamamura","year":"1998","journal-title":"Br J Haematol"},{"issue":"4","key":"2020042008481937200_B58","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.21918","article-title":"Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): shedding of soluble IL-6R and activation of STAT3 signaling","volume":"119","author":"Horiuchi","year":"2006","journal-title":"Int J Cancer"},{"issue":"3","key":"2020042008481937200_B59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/ejh.12231","article-title":"Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia\/lymphoma mouse model","volume":"92","author":"Mori","year":"2014","journal-title":"Eur J Haematol"}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2020001997","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/6\/1062\/1724758\/advancesadv2019001429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/6\/1062\/1724758\/advancesadv2019001429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T12:48:58Z","timestamp":1587386938000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/6\/1062\/452722\/Proteomic-profiling-of-HTLV1-carriers-and-ATL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001429","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/bloodadvances.2020001997","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}